Send the following on WhatsApp
Continue to Chat未受 Aduhelm 裁決影響,Eisai、Biogen 提交另一項阿茲海默症藥物申請 https://geneonline.news/lecanemab-alzheimers-disease-fda/
未受 Aduhelm 裁決影響,Eisai、Biogen 提交另一項阿茲海默症藥物申請 https://geneonline.news/lecanemab-alzheimers-disease-fda/